Anastasiia Priss

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Structural Basis

Cell Cycle Arrest

Respiratory Syndrome Coronavirus

Top Venues

Journal of neurochemistry

Chemical record (New York, N.Y.)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Žáčková, Marcela Pávová, Jana Trylčová, Jitka Chalupová, Anastasiia Priss, Ondřej Lukšan, Jan Weber
Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected Lung Adenocarcinoma Calu-3 Cells. Cells 13 (10) (2024)
Sandra Žáčková, Marcela Pávová, Jana Trylčová, Jitka Chalupová, Anastasiia Priss, Ondřej Lukšan, Jan Weber
Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected Lung Adenocarcinoma Calu-3 Cells. Cells 13 (10) (2024)
Maksym Galkin, Oleksandra Topcheva, Anastasiia Priss, Tatiana Borisova, Volodymyr V Shvadchak
Dopamine-Induced Oligomers of α-Synuclein Inhibit Amyloid Fibril Growth and Show No Toxicity. ACS chemical neuroscience (2023)
Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha, Volodymyr V Shvadchak
Navigating α-Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets. Chemical record (New York, N.Y.) (2023)
Anastasiia Priss, Kseniia Afitska, Maksym Galkin, Dmytro A Yushchenko, Volodymyr V Shvadchak
Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells. Journal of medicinal chemistry 64 (10) (2021)
Maksym Galkin, Anastasiia Priss, Oleksandra Topcheva, Dmytro A Yushchenko, Volodymyr V Shvadchak
FRET-based assay for intracellular evaluation of α-synuclein aggregation inhibitors. Journal of neurochemistry 159 (5) (2021)